Treatment of malignant pleural mesothelioma

Annals of Thoracic Medicine

Volumn 5, Issue SUPPL. 1, 2010, Pages

  Alolayan, Ashwaq ^a   Saadeddin, Ahmed ^b   Bamousa, Ahmed ^b   Jazieh, Abdul Rahman ^a  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b Prince Sultan Military Medical City   (Saudi Arabia)

Author keywords

Lung cancer; malignant; pleural mesothelioma

Indexed keywords

EID: 84898892142     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Tsao AS, Wistuba I, Roth JA, Kindler HL. Malignant pleural mesothelioma. J Clin Oncol 2009;27:2081-90.
2. Boutin C, Rey F, Viallat JR. Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: A randomized trial of local radiotherapy. Chest 1995;108:754-8.
3. Weder W, Stahel RA, Bernhard J, Bodis S, Vogt P, Ballabeni P, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007;18:1196-202.
4. Weder W, Kestenholz P, Taverna C, Bodis S, Lardinois D, Jerman M, et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 2004;22:3451-7.
5. Butchart EG. Contemporary management of malignant pleural Mesothelioma. Oncologist 1999;4:488-500.
6. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44.
7. van Meerbeeck JP, Gaafar R, Manegold C, van Klaveren RJ, van Marck EA, Vincent M, et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 2005;23:6881-9.
8. Buduhan G, Menon S, Aye R, Louie B, Mehta V, Vallieres E. Trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 2009;88:870-6.
9. Sugarbaker DJ, Strauss GM, Lynch TJ, Richards W, Mentzer SJ, Lee TH, et al. Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 1993;11:1172-8.
10. Maziak DE, Gagliardi A, Haynes AE, Mackay JA, Evans WK. Cancer care ontario program in evidence-based care lung cancer disease site group. Surgical management of malignant pleural mesothelioma: A systematic review and evidence summary. Lung Cancer 2005;48:157-69. Epub 2005 Jan 5.
11. Cameron RB. Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument. Ann Surg Oncol 2007;14:1249-53. Epub 2006 Oct 25.
12. Flores RM. Surgical option in malignant pleural mesothelioma: Extrapleural pneumonectomy or pleurectomy/decortification. Semin Thorac Cardiovasc Surg 2009;21:149-53.
13. van Ruth S, Baas P, Zoetmulder FA. Surgical treatment of malignant pleural mesothelioma: A review. Chest 2003;123:551-61.
14. Yan TD, Boyer M, Tin MM, Wong D, Kennedy C, Mclean J, et al. Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors. J Thorac Cardiovasc Surg 2009; 138:619-24. Epub 2009 Mar 9.
15. Gupta V, Mychalczak B, Krug L, Flores R, Bains M, Rusch VW, et al. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2005;63:1045-52.
16. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007;84:1685-92; discussion 1692-3.
17. Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009;27:3007-13.
18. Ceresoli GL, Castagneto B, Zucali PA, Favaretto A, Mencoboni M, Grossi F, et al. Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: Combined analysis of two phase II trials. Br J cancer 2008;99(1):51-6. Epub 2008 Jun 10.
19. Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, et al . Phase III study of pemetrexed in combination with cisplatin versus cispaltin of alone in patients with malignant pleural mesothliomia. J Clin Oncol 2003:21:2636-44.
20. Jazieh AR. The process of guideline development. Annals of Thoracic Medicine-Supplement Lung Cancer Guidelines; 2008. p. S60-1.